chr8-115418315-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014112.5(TRPS1):c.2823+15C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 1,614,074 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 5 hom. )
Consequence
TRPS1
NM_014112.5 intron
NM_014112.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.687
Publications
0 publications found
Genes affected
TRPS1 (HGNC:12340): (transcriptional repressor GATA binding 1) This gene encodes a transcription factor that represses GATA-regulated genes and binds to a dynein light chain protein. Binding of the encoded protein to the dynein light chain protein affects binding to GATA consensus sequences and suppresses its transcriptional activity. Defects in this gene are a cause of tricho-rhino-phalangeal syndrome (TRPS) types I-III. [provided by RefSeq, Jul 2008]
TRPS1 Gene-Disease associations (from GenCC):
- trichorhinophalangeal syndrome type IInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- trichorhinophalangeal syndrome, type IIIInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- trichorhinophalangeal syndrome type I or IIIInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 8-115418315-G-T is Benign according to our data. Variant chr8-115418315-G-T is described in ClinVar as Benign. ClinVar VariationId is 260332.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00147 (224/152286) while in subpopulation NFE AF = 0.00254 (173/68018). AF 95% confidence interval is 0.00223. There are 0 homozygotes in GnomAd4. There are 92 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 224 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRPS1 | NM_014112.5 | c.2823+15C>A | intron_variant | Intron 6 of 6 | ENST00000395715.8 | NP_054831.2 | ||
| TRPS1 | NM_001282903.3 | c.2802+15C>A | intron_variant | Intron 6 of 6 | NP_001269832.1 | |||
| TRPS1 | NM_001282902.3 | c.2796+15C>A | intron_variant | Intron 5 of 5 | NP_001269831.1 | |||
| TRPS1 | NM_001330599.2 | c.2784+15C>A | intron_variant | Intron 5 of 5 | NP_001317528.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00147 AC: 224AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
224
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00170 AC: 424AN: 249554 AF XY: 0.00182 show subpopulations
GnomAD2 exomes
AF:
AC:
424
AN:
249554
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00187 AC: 2731AN: 1461788Hom.: 5 Cov.: 31 AF XY: 0.00196 AC XY: 1427AN XY: 727196 show subpopulations
GnomAD4 exome
AF:
AC:
2731
AN:
1461788
Hom.:
Cov.:
31
AF XY:
AC XY:
1427
AN XY:
727196
show subpopulations
African (AFR)
AF:
AC:
21
AN:
33472
American (AMR)
AF:
AC:
106
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
100
AN:
26134
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
49
AN:
86258
European-Finnish (FIN)
AF:
AC:
8
AN:
53412
Middle Eastern (MID)
AF:
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2329
AN:
1111934
Other (OTH)
AF:
AC:
109
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
168
336
505
673
841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00147 AC: 224AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.00124 AC XY: 92AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
224
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
92
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
9
AN:
41556
American (AMR)
AF:
AC:
20
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
10
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
173
AN:
68018
Other (OTH)
AF:
AC:
11
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Trichorhinophalangeal dysplasia type I;C1860823:Trichorhinophalangeal syndrome, type III Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.